For the General Public
CERN is publicly funded by its 23 Member States and Associate Member States. Find out below about how this investment creates a positive impact on society.
BAQ, a start-up using CERN technologies, tackles radon in buildings.
A portable RFQ acclerator expects to open up for new possibilities in art studies.
The start-up Camstech Ltd joined the STFC-CERN Business Incubation Centre in 2016.
CELESTA stands for CERN Latchup Experiments Student sAtellite and will be the first CERN-driven microsatellite.
The collaboration agreement between CERN and ESA, signed in July 2019, addresses the challenge of operating in harsh radiation environments found in both particle-physics facilities and outer space.
FastIC project catching the attention of the Medical Imaging industry.
A team of experts from CERN shared their expertise on machine learning with Sanofi Pasteur, the vaccines business unit of Sanofi, a global life sciences company.
In March 2020, a working group was established by CERN Director-General Fabiola Gianotti as a response to the wealth of ideas and proposals put forward by the CERN community in contribution to the global fight against COVID-19
2019 saw the official launch of the Next Ion Medical Machine Study (NIMMS), an umbrella R&D programme for – both existing and new – CERN accelerator technologies linked to heavy-ion therapy.